ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

July 25, 1986

French Cancer Group Vow to Spend More On Cancer Research

January 12, 1996

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

Tim Lee Carter Named Chairman Of NCAB; Five Others Appointed

June 11, 1982

NCI Cooperative Group, Cancer Center Trials Listed

February 29, 2008